RxDoctor Payments Data

Jane Kang, MD

Psychiatry · North Little Rock, ARNPI 1174637755

Payments from drug & device makers

$1,456in general payments, 2019–2025

Across 66 payments — averaging $22.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$403
  • Johnson & Johnson$232
  • Alkermes, Inc.$220
  • Otsuka America Pharmaceutical, Inc.$169
  • Teva Pharmaceuticals USA, Inc.$160
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$125
  • plus $147 from 7 others

What the payments were for

  • Food & beverage$1,31290%
  • Education$14410%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,456 in reported general payments places this provider in the 70th percentile of 235 psychiatry providers in Arkansas.

See all psychiatry providers in Arkansas

Medicare billing

Part B allowed, 2024
$26,909
Medicare patients
98
Services billed
247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole16$49,724
CaplytaLumateperone Tosylate12$18,748
Lisdexamfetamine Dimesylate12$2,654
Quetiapine Fumarate44$2,141
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine25$1,184
Duloxetine Hcl73$924
Venlafaxine Hcl ErVenlafaxine Hcl21$896
Modafinil11$850
Desvenlafaxine Succinate ErDesvenlafaxine Succinate11$838
Buspirone Hcl60$828
Oxcarbazepine20$714
Bupropion XlBupropion Hcl36$676
Doxepin Hcl20$552
Mirtazapine41$502
Olanzapine23$494

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$169$49,72416 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$125$18,74812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 235 psychiatry providers in Arkansas.

Other psychiatry in North Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →